Global Pharmaceutical Excipients Market - Forecasts From 2018 to 2023
The global pharmaceutical excipients market is expected to reach US$7.790 billion by 2023 from US$5.181 billion in 2017 growing at a CAGR of 7.03%. Excipients are the pharmacologically inactive substances added along with the active drug substance to streamline the manufacture of the drug product and aid in lubricity, flowability, disintegration, taste and may confer some form of antimicrobial function, also facilitating physiological absorption of the drug. Some of the excipients used in pharmaceutical industries include fillers, binders, lubricants, flavouring agents, sweeteners, solvents and co solvents, chelating agents etc. To provide the bulk finished dosage formulations that are consistent in physical and chemical, the formulator is highly dependent on the pharmaceutical excipients. The market is expected to show a significant growth during the given forecast period. The growth may be attributed to the growth in the pharmaceutical industry further leading to the rise in the demand of the excipients for the formulation. However, stringent regulatory guideline laid down by various regulatory bodies across the globe might hamper the growth of the market during the given time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global pharmaceutical excipients market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global pharmaceutical excipients market.
Major industry players profiled as part of the report are BASF SE, Avantor, Inc. and JRS Pharma GmbH & Co. KG among others.
Segmentation
By Excipient Type
Polymers
Alcohols
Sugars
Minerals
Others
By Formulation Type
Oral
Topical
Parenteral
Others
By Functionality
Coating Agents
Flavoring Agents & Sweeteners
Lubricants & Glidants
Colorants
Emulsifying Agents
Buffering Agents
Others
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global pharmaceutical excipients market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global pharmaceutical excipients market.
Major industry players profiled as part of the report are BASF SE, Avantor, Inc. and JRS Pharma GmbH & Co. KG among others.
Segmentation
By Excipient Type
Polymers
Alcohols
Sugars
Minerals
Others
By Formulation Type
Oral
Topical
Parenteral
Others
By Functionality
Coating Agents
Flavoring Agents & Sweeteners
Lubricants & Glidants
Colorants
Emulsifying Agents
Buffering Agents
Others
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY EXCIPIENT TYPE
5.1. Polymers
5.2. Alcohols
5.3. Sugars
5.4. Minerals
5.5. Others
6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY FORMULATION TYPE
6.1. Oral
6.2. Topical
6.3. Parenteral
6.4. Others
7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY FUNCTIONALITY
7.1. Coating Agents
7.2. Flavoring Agents & Sweeteners
7.3. Lubricants & Glidants
7.4. Colorants
7.5. Emulsifying Agents
7.6. Buffering Agents
7.7. Others
8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Avantor, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
11. SIGNET CHEMICAL CORPORATION PVT. LTD.
10.2. Signet Chemical Corporation Pvt. Ltd.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. NB Entrepreneurs
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. JRS Pharma GmbH & Co. KG
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Colorcon
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Croda International Plc
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. ABF Ingredients
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. DFE Pharma
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. BASF SE
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Fuji Chemical Industries Co., Ltd.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
10.11. The Dow Chemical Company
10.11.1. Overview
10.11.2. Financials
10.11.3. Product and Services
10.11.4. Recent Developments
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY EXCIPIENT TYPE
5.1. Polymers
5.2. Alcohols
5.3. Sugars
5.4. Minerals
5.5. Others
6. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY FORMULATION TYPE
6.1. Oral
6.2. Topical
6.3. Parenteral
6.4. Others
7. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY FUNCTIONALITY
7.1. Coating Agents
7.2. Flavoring Agents & Sweeteners
7.3. Lubricants & Glidants
7.4. Colorants
7.5. Emulsifying Agents
7.6. Buffering Agents
7.7. Others
8. GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Avantor, Inc.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
11. SIGNET CHEMICAL CORPORATION PVT. LTD.
10.2. Signet Chemical Corporation Pvt. Ltd.
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. NB Entrepreneurs
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. JRS Pharma GmbH & Co. KG
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Colorcon
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Croda International Plc
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. ABF Ingredients
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. DFE Pharma
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. BASF SE
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Fuji Chemical Industries Co., Ltd.
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
10.11. The Dow Chemical Company
10.11.1. Overview
10.11.2. Financials
10.11.3. Product and Services
10.11.4. Recent Developments
